NT5E and inflammatory bowel disease: On the other hand, despite evidence showing that MTX and sulfasalazine, two drugs currently used to treat IBD, act by stimulating NT5E/CD73-dependent adenosine production (Ochoa-Cortes et al., 2014), the role of NT5E/CD73 is still unclear.